Wells Fargo’s Biostage, Inc. Common Stock BSTG Stock Holding History

Wells Fargo’s Portfolio BSTG Stock Details BSTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-23,487	Closed	-$9K	–	6645
2017 Q1	$9K	Buy	23,487 +12,987	+124%	+$7.11K	﹤0.01%	5914
2016 Q4	$9K	Buy	10,500 +5,000	+91%	+$4.46K	﹤0.01%	5844
2016 Q3	$6K	Buy	+5,500	New	+$5.92K	﹤0.01%	5893
2016 Q2	–	Sell	-1	Closed	–	–	6536
2016 Q1	$0	Hold	1	–	–	﹤0.01%	6616
2015 Q4	$0	Sell	1 -1,500	-100%	-$2.09K	﹤0.01%	6583
2015 Q3	$1K	Hold	1,501	–	–	﹤0.01%	6130
2015 Q2	$2K	Sell	1,501 -100	-6%	-$245	﹤0.01%	6192
2015 Q1	$5K	Buy	1,601 +100	+7%	+$341	﹤0.01%	5841
2014 Q4	$5K	Hold	1,501	–	–	﹤0.01%	5878
2014 Q3	$12K	Hold	1,501	–	–	﹤0.01%	5521
2014 Q2	$16K	Hold	1,501	–	–	﹤0.01%	5479
2014 Q1	$14K	Hold	1,501	–	–	﹤0.01%	5319
2013 Q4	$7K	Buy	+1,501	New	+$7.02K	﹤0.01%	5289

Other funds holding BSTG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

GWI

Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo's BSTG Position: Q2 2017 in Review

Wells Fargo sold out of Biostage, Inc. Common Stock (BSTG) in Q2 2017, closing a stake of 23,487 shares — an estimated $9K sold.

Wells Fargo first reported a position in BSTG in Q4 2013 and held it in 13 quarters. The position peaked at $16K in Q2 2014. 24 funds tracked by Wall St. Rank hold BSTG as of Q2 2017.

Wells Fargo reported no remaining Biostage, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
Wells Fargo sold 23,487 Biostage, Inc. Common Stock shares in Q2 2017, an estimated $9K.
Wells Fargo first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 13 quarters.
Wells Fargo's Biostage, Inc. Common Stock position peaked at $16K in Q2 2014.
24 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q2 2017.

Based on Wells Fargo's 13F filing for Q2 2017, filed 10 Aug 2017.